Marion Ciudad

Besancon, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Mature CD209+CD83+CCR7+ dendritic cells infiltrate the arterial wall in giant cell arteritis and derive from in-situ monocyte differentiation.

Mature CD209+CD83+CCR7+ dendritic cells infiltrate the arterial wall in giant cell arteritis and derive from in-situ monocyte differentiation.

Journal: Scientific reports
Published: July 10, 2025

In Synergy With Interferon-γ, Interleukin-17 Activates Vascular Stromal Cells Toward a Proinflammatory Profile in Giant Cell Arteritis.

In Synergy With Interferon-γ, Interleukin-17 Activates Vascular Stromal Cells Toward a Proinflammatory Profile in Giant Cell Arteritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 24, 2025

Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica.

Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica.

Journal: RMD open
Published: May 02, 2024

Pro-angiogenic changes of T-helper lymphocytes in hereditary hemorrhagic telangiectasia.

Pro-angiogenic changes of T-helper lymphocytes in hereditary hemorrhagic telangiectasia.

Journal: Frontiers in immunology
Published: October 13, 2023

Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization.

Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization.

Journal: Haematologica
Published: February 03, 2023

Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis.

Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis.

Journal: Frontiers in immunology
Published: January 04, 2023

T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients.

T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients.

Journal: European journal of internal medicine
Published: May 03, 2022

Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD.

Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD.

Journal: Frontiers in immunology
Published: December 03, 2021

Mucosal-associated invariant T cells in Giant Cell Arteritis.

Mucosal-associated invariant T cells in Giant Cell Arteritis.

Journal: Journal of autoimmunity
Published: March 18, 2021

Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.

Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.

Journal: HemaSphere
Published: March 11, 2021

Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect.

Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect.

Journal: Oncoimmunology
Published: March 04, 2021

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis.

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis.

Journal: Clinical & translational immunology
Published: January 25, 2021
Showing 1-12 of 20

Last Updated: 09/26/2026